| Takeda Pharma AG - Elvanse 60 mg, Hartkapseln | | 63023 | | 06 | | Elvanse 60 mg | | Hartkapseln | | N06BA12 | | Lisdexamfetamine | | 16.11.2016 | | |
| | Composition | | lisdexamfetamini dimesilas 60 mg corresp. dexamfetaminum 17.8 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 133, E 171, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.3146 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| Lisdexamfetamini Dimesilas | 60 mg correspond Dexamfetaminum 17.8 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lisdexamfetamini Dimesilas | 60 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Nigrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 133 | | color. | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 006 | 30 | 107.18 | 129.70 | A+ | LS | Oui |
|
|
